Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Depreciation & Amortization (CF) (2018 - 2026)

Health Catalyst filings provide 9 years of Depreciation & Amortization (CF) readings, the most recent being $12.1 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 1.66% to $12.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $50.3 million, a 16.35% increase, with the full-year FY2025 number at $50.5 million, up 21.89% from a year prior.
  • Depreciation & Amortization (CF) hit $12.1 million in Q1 2026 for Health Catalyst, down from $12.9 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $12.9 million in Q4 2025 to a low of $10.0 million in Q3 2024.
  • Median Depreciation & Amortization (CF) over the past 5 years was $11.6 million (2022), compared with a mean of $11.4 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 54.96% in 2022 and later fell 17.64% in 2023.
  • Health Catalyst's Depreciation & Amortization (CF) stood at $11.7 million in 2022, then decreased by 11.66% to $10.3 million in 2023, then decreased by 0.37% to $10.3 million in 2024, then grew by 25.48% to $12.9 million in 2025, then dropped by 5.95% to $12.1 million in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $12.1 million (Q1 2026), $12.9 million (Q4 2025), and $12.6 million (Q3 2025) per Business Quant data.